Lifetime Achievement Award, lecanemab and biomarkers in focus at CTAD
Barnes Group, Inc. (B)
Last barnes group, inc. earnings: 4/24 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
ir.barnesgroupinc.com/investor-relations/overview/default.aspx
Company Research
Source: PR Newswire
STOCKHOLM, Oct. 24, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) founder Lars Lannfelt will be presented with the Lifetime Achievement Award in Alzheimer's Disease Therapeutic Research at the Clinical Trials for Alzheimer's Disease Conference (CTAD) held in Madrid, Spain, and virtually from October 29 to November 1. Lars Lannfelt will be one of the keynote speakers at the conference. In addition, BioArctic's partner Eisai present lecanemab data in two oral and one poster presentation at the meeting and three symposia will focus on lecanemab. Data shared will include the importance of continued treatment of Alzheimer's disease, a progressive neurodegenerative disease that begins before plaque deposition and continues after plaque removal.At CTAD 2024, Eisai will present the latest information on the use of lecanemab in clinical practice and the use of plasma biomarkers in the AHEAD 3-45 trial to screen for preclinical Alzheimer's disease. The full list of prese
Show less
Read more
Impact Snapshot
Event Time:
B
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
B alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
B alerts
High impacting Barnes Group, Inc. news events
Weekly update
A roundup of the hottest topics
B
News
- Barnes Group Inc. (NYSE: B) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Barnes Group Inc. (NYSE: B) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- BrainTransporterâ„¢ dramatically improves antibody delivery to the brainPR Newswire
- BrainTransporterâ„¢ dramatically improves antibody delivery to the brainPR Newswire
- Precision Parts Market Focused Insights Report 2024-2029 Featuring Key Vendors - ARC Group, Barnes, Linamar, Martinrea, NN, Renishaw, Regal Rexnord, and Suprajit [Yahoo! Finance]Yahoo! Finance
B
Earnings
- 10/25/24 - Miss
B
Sec Filings
- 11/13/24 - Form PREM14A
- 11/8/24 - Form SC
- 11/5/24 - Form 4
- B's page on the SEC website